CD8A and Miyoshi myopathy: This fact comes in agreement with higher percentages of CD3+ T-cells, reduced Tregs, and decreased expression of immune-checkpoint receptors in CD8+ T-cells in the BM of patients with newly diagnosed MM compared to BM niche of patients with EMD [15,16].